740 related articles for article (PubMed ID: 11162661)
21. Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG.
Kang J; Wang L; Chen XL; Triggle DJ; Rampe D
Mol Pharmacol; 2001 Jan; 59(1):122-6. PubMed ID: 11125032
[TBL] [Abstract][Full Text] [Related]
22. Time course and voltage dependence of expressed HERG current compared with native "rapid" delayed rectifier K current during the cardiac ventricular action potential.
Hancox JC; Levi AJ; Witchel HJ
Pflugers Arch; 1998 Nov; 436(6):843-53. PubMed ID: 9799397
[TBL] [Abstract][Full Text] [Related]
23. Blockade of the HERG human cardiac K(+) channel by the antidepressant drug amitriptyline.
Jo SH; Youm JB; Lee CO; Earm YE; Ho WK
Br J Pharmacol; 2000 Apr; 129(7):1474-80. PubMed ID: 10742304
[TBL] [Abstract][Full Text] [Related]
24. Direct effects of candesartan and eprosartan on human cloned potassium channels involved in cardiac repolarization.
Caballero R; Delpón E; Valenzuela C; Longobardo M; González T; Tamargo J
Mol Pharmacol; 2001 Apr; 59(4):825-36. PubMed ID: 11259627
[TBL] [Abstract][Full Text] [Related]
25. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature.
Zhou Z; Gong Q; Ye B; Fan Z; Makielski JC; Robertson GA; January CT
Biophys J; 1998 Jan; 74(1):230-41. PubMed ID: 9449325
[TBL] [Abstract][Full Text] [Related]
26. Blockade of HERG and Kv1.5 by ketoconazole.
Dumaine R; Roy ML; Brown AM
J Pharmacol Exp Ther; 1998 Aug; 286(2):727-35. PubMed ID: 9694927
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels.
Kiehn J; Thomas D; Karle CA; Schöls W; Kübler W
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):212-9. PubMed ID: 10208308
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the human ether-a-go-go-related gene (HERG) potassium channel by cisapride: affinity for open and inactivated states.
Walker BD; Singleton CB; Bursill JA; Wyse KR; Valenzuela SM; Qiu MR; Breit SN; Campbell TJ
Br J Pharmacol; 1999 Sep; 128(2):444-50. PubMed ID: 10510456
[TBL] [Abstract][Full Text] [Related]
29. Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride.
Mohammad S; Zhou Z; Gong Q; January CT
Am J Physiol; 1997 Nov; 273(5):H2534-8. PubMed ID: 9374794
[TBL] [Abstract][Full Text] [Related]
30. Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action.
Busch AE; Eigenberger B; Jurkiewicz NK; Salata JJ; Pica A; Suessbrich H; Lang F
Br J Pharmacol; 1998 Jan; 123(1):23-30. PubMed ID: 9484850
[TBL] [Abstract][Full Text] [Related]
31. Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides.
Spector PS; Curran ME; Keating MT; Sanguinetti MC
Circ Res; 1996 Mar; 78(3):499-503. PubMed ID: 8593709
[TBL] [Abstract][Full Text] [Related]
32. Losartan and its metabolite E3174 modify cardiac delayed rectifier K(+) currents.
Caballero R; Delpón E; Valenzuela C; Longobardo M; Tamargo J
Circulation; 2000 Mar; 101(10):1199-205. PubMed ID: 10715269
[TBL] [Abstract][Full Text] [Related]
33. Open channel block by KCB-328 [1-(2-amino-4-methanesulfonamidophenoxy)-2-[N-(3,4-dimethoxyphenethyl)-N-methylamino]ethane hydrochloride] of the heterologously expressed human ether-a-go-go-related gene K+ channels.
Park JB; Choe H; Lee YK; Ha KC; Rhee KS; Ko JK; Joo CU; Chae SW; Kwak YG
J Pharmacol Exp Ther; 2002 Jul; 302(1):314-9. PubMed ID: 12065732
[TBL] [Abstract][Full Text] [Related]
34. Block of HERG-carried K+ currents by the new repolarization delaying agent H 345/52.
Amos GJ; Jacobson I; Duker G; Carlsson L
J Cardiovasc Electrophysiol; 2003 Jun; 14(6):651-8. PubMed ID: 12875428
[TBL] [Abstract][Full Text] [Related]
35. High affinity blockade of the HERG cardiac K(+) channel by the neuroleptic pimozide.
Kang J; Wang L; Cai F; Rampe D
Eur J Pharmacol; 2000 Mar; 392(3):137-40. PubMed ID: 10762666
[TBL] [Abstract][Full Text] [Related]
36. The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines.
Kupershmidt S; Yang IC; Hayashi K; Wei J; Chanthaphaychith S; Petersen CI; Johns DC; George AL; Roden DM; Balser JR
FASEB J; 2003 Dec; 17(15):2263-5. PubMed ID: 14525949
[TBL] [Abstract][Full Text] [Related]
37. Effects of fluoroquinolones on HERG currents.
Bischoff U; Schmidt C; Netzer R; Pongs O
Eur J Pharmacol; 2000 Oct; 406(3):341-3. PubMed ID: 11040340
[TBL] [Abstract][Full Text] [Related]
38. Open channel block of HERG K(+) channels by vesnarinone.
Kamiya K; Mitcheson JS; Yasui K; Kodama I; Sanguinetti MC
Mol Pharmacol; 2001 Aug; 60(2):244-53. PubMed ID: 11455010
[TBL] [Abstract][Full Text] [Related]
39. Molecular determinants of hERG potassium channel inhibition by disopyramide.
El Harchi A; Zhang YH; Hussein L; Dempsey CE; Hancox JC
J Mol Cell Cardiol; 2012 Jan; 52(1):185-95. PubMed ID: 21989164
[TBL] [Abstract][Full Text] [Related]
40. The long QT syndrome: new diagnostic and therapeutic approach in the era of molecular biology.
Priori SG; Cantù F; Schwartz PJ
Schweiz Med Wochenschr; 1996 Oct; 126(41):1727-31. PubMed ID: 8893413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
